2370013-12-8 Sunvozertinib

Properties

Appearance Off-white to light brown Solid
Density 1.35±0.1 g/cm3
storage temp. Store at -20°C
pka12.29±0.70
 

Application:

Sunvozertinib is a drug used to treat locally advanced or metastatic non-small cell lung cancer (NSCLC), primarily targeting patients with EGFR (epidermal growth factor receptor) exon 20 insertion mutations
 

 

Synonyms:

sunvozertinib

2370013-12-8

DZD-9008

ASYM-122507

DZ-0586

N-[5-[[4-[5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino]pyrimidin-2-yl]amino]-2-[(3R)-3-(dimethylamino)pyrrolidin-1-yl]-4-methoxyphenyl]prop-2-enamide

A1801

A-1801

2-Propenamide, N-(5-((4-((5-chloro-4-fluoro-2-(1-hydroxy-1-methylethyl)phenyl)amino)-2-pyrimidinyl)amino)-2-((3R)-3-(dimethylamino)-1-pyrrolidinyl)-4-methoxyphenyl)-

Example 52 

N-(5-((4-(5-chloro-4-fluoro-2-(2-hydroxypropan-2-yl)anilino)pyrimidin-2-yl)amino)-2-((3R)-3-(dimethylamino)pyrrolidin-1-yl)-4-methoxyphenyl)prop-2-enamide

 

 

Hot Tags: 2370013-12-8 sunvozertinib, China 2370013-12-8 sunvozertinib manufacturers, suppliers, 1 8 Octanediol, Taurochenodeoxycholic acid sodiuM salt, N-Benzoylaminopurine, Pcbma, Tributyl 1 ethoxyvinyl stannane, 2 Phenylbutyric acid